INSIG1
INSIG1 (insulin induced gene 1, also known as CL-6 and MGC1405) is an oxysterol-binding protein of the endoplasmic reticulum membrane. It provides feedback control of cholesterol synthesis by restraining SCAP-SREBP trafficking and promoting HMGCR degradation. Browse Assay Genie's current range of INSIG1 research reagents below, or read on for the biology behind the target.
INSIG1 mediates feedback control of cholesterol synthesis. It acts as a negative regulator of cholesterol biosynthesis by retaining the SCAP-SREBP complex in the endoplasmic reticulum, which blocks the processing of the sterol regulatory element-binding proteins SREBF1/SREBP1 and SREBF2/SREBP2. When oxysterol, including 25-hydroxycholesterol, is bound, INSIG1 interacts with SCAP and prevents SCAP from escorting the SREBPs to the Golgi.
Sterol deprivation, or phosphorylation by PCK1, reduces oxysterol binding and disrupts the INSIG1-SCAP interaction. The SCAP-SREBP complex can then move to the Golgi, followed by processing and nuclear translocation of SREBP1 and SREBP2. INSIG1 also controls HMGCR (HMG-CoA reductase) levels. It initiates sterol-mediated, ubiquitin-dependent endoplasmic reticulum-associated degradation (ERAD) of HMGCR by recruiting the reductase to the ubiquitin ligases AMFR/gp78 and/or RNF139. When lipid levels are low, it likewise initiates ubiquitin-mediated degradation of SOAT2/ACAT2 through recruitment of AMFR/gp78.
The INSIG1 gene encodes an endoplasmic reticulum membrane protein with six transmembrane helices that contain an effector protein binding site. It binds the sterol-sensing domains of SCAP and HMG-CoA reductase and is essential for the sterol-mediated trafficking of both proteins. Beyond cholesterol metabolism, the NCBI Gene summary links it to lipogenesis and glucose homeostasis. INSIG1 belongs to the INSIG family, and alternative splicing gives rise to multiple transcript variants.
INSIG1 provides feedback control of cholesterol synthesis, making it a central protein for studying sterol sensing and regulation of biosynthesis.
By retaining the SCAP-SREBP complex in the endoplasmic reticulum, INSIG1 gates SREBP1 and SREBP2 processing and nuclear translocation.
INSIG1 recruits HMGCR and SOAT2/ACAT2 to ubiquitin ligases such as AMFR/gp78, offering a model for regulated ER-associated degradation.
INSIG1 is reported to regulate lipogenesis and glucose homeostasis, linking sterol control to wider metabolic studies.
INSIG1 is an oxysterol-binding protein that mediates feedback control of cholesterol synthesis. It retains the SCAP-SREBP complex in the endoplasmic reticulum and initiates ubiquitin-mediated degradation of HMGCR, thereby limiting cholesterol biosynthesis when sterol levels are sufficient.
The HGNC name is insulin induced gene 1, and UniProt lists the protein as insulin-induced gene 1 protein. Aliases include CL-6 and MGC1405. Alternative splicing of the INSIG1 gene results in multiple transcript variants.
Yes. Mouse and rat both have an ortholog named Insig1. The protein belongs to the INSIG family. Check the datasheet of any product for its validated reactivity.
Binding partners, SREBP pathway components and ubiquitin ligases that act with INSIG1 in sterol regulation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O15503; product specifications from Assay Genie datasheets.